Abstract
Context
African American women (AAW) have a higher incidence of insulin resistance and are at a greater risk for the development of obesity and type 2 diabetes than Caucasian women (CW). Although several factors have been proposed to mediate these racial disparities, the mechanisms remain poorly defined. We previously demonstrated that sedentary lean AAW have lower peripheral insulin sensitivity, reduced maximal aerobic fitness (VO2max), and lower resting metabolic rate (RMR) than CW. We have also demonstrated that skeletal muscle mitochondrial respiration is lower in AAW and appears to play a role in these racial differences.
Objective
The goal of this study was to assess mitochondrial pathways and dynamics to examine the potential mechanisms of lower insulin sensitivity, RMR, VO2max, and mitochondrial capacity in AAW.
Design
To achieve this goal, we assessed several mitochondrial pathways in skeletal muscle using gene array technology and semiquantitative protein analysis.
Results
We report alterations in mitochondrial pathways associated with inner membrane small molecule transport genes, fusion–fission, and autophagy in lean AAW. These differences were associated with lower insulin sensitivity, RMR, and VO2max.
Conclusions
Together these data suggest that the metabolic racial disparity of insulin resistance, RMR, VO2max, and mitochondrial capacity may be mediated by perturbations in mitochondrial pathways associated with membrane transport, fission–fusion, and autophagy. The mechanisms contributing to these differences remain unknown.
Keywords: African American women, skeletal muscle, mitochondria
African American women (AAW) have a 2-fold greater incidence of developing type 2 diabetes than Caucasian women (CW) (1–4). This racial disparity is also observed in African American and Caucasian men, but to a lesser extent (5). Although the mechanisms remain unclear, there is growing evidence that insulin sensitivity is lower in African Americans controlling for factors known to contribute to impaired insulin action like obesity. Paradoxically, visceral and hepatic fat, generally considered strong correlates of lower insulin sensitivity (6) are lower in AAW (7–9). In support of these observations, we reported that lean (body mass index [BMI] 22.7 ± 3.1 kg/m2) AAW have lower peripheral insulin sensitivity, lower maximal aerobic fitness (VO2max), and impaired skeletal muscle mitochondrial capacity than BMI-matched CW (10). Lower resting metabolic rate (RMR), which may contribute to the development of obesity, has been consistently shown in AAW (11, 12) than CW, and may be associated with mitochondrial impairment (13). Yet, our understanding of the mechanisms potentially contributing to the racial disparity in mitochondrial function is unclear.
The association between mitochondrial function and insulin resistance is controversial (14–16). Several key observations suggest that mitochondrial pathways including metabolic inflexibility (17, 18), oxidative stress (19), and chronic inflammation (20) mediate skeletal muscle insulin resistance. On the other hand, acute high-fat feeding in rodents (21) and humans (22) results in mitochondrial biogenesis and increased oxidative capacity. Nevertheless, pathways associated with mitochondrial remodeling (eg, fission and fusion) are correlated with levels of insulin sensitivity in both humans (23, 24) and rodents (25, 26). Moreover, proteins in the fission and fusion pathways respond to increased levels of physical activity (27, 28) and changes in diet (29). Together these data suggest that multiple mitochondrial pathways likely contribute to insulin sensitivity and may contribute to the observed racial disparity of insulin resistance.
The primary goal of this study was to determine if skeletal muscle mitochondrial dynamics are impaired in lean AAW compared with lean CW. To achieve this goal, we examined several mitochondrial pathways including membrane polarization and potential, translocation, and transport in human skeletal muscle using gene array technology. In addition, expression of mitochondrial proteins of the fission and fusion, localization, and apoptosis pathways were examined. These pathways were then correlated with measures of peripheral insulin sensitivity, aerobic fitness, resting metabolic rate, and mitochondrial capacity.
Materials and Methods
Subjects
Twenty-two AAW and 22 CW women aged 18.7 to 38.3 years were recruited for the study from print advertisements in the Pittsburgh area. All included subjects were sedentary by self-report (≤20 minutes of intentional exercise, 3 times per week), not pregnant or lactating, and weight stable (<±3 kg in the previous 6 months). Subjects were excluded for unstable medical conditions, smoking, metabolic disease (eg, diabetes mellitus), or medication use that would affect the primary outcome measures. Prior to the initiation of the testing procedures, all subjects provided informed consent, and were medically screened and cleared. The protocol was approved by the University of Pittsburgh Institutional Review Board.
Study protocol
The details of the study protocol and the subject characteristics have been published elsewhere (10). Briefly, after enrollment in the study, subjects reported to the Endocrinology and Metabolism Research Center for a body composition assessment using dual-energy X-ray absorptiometry (Lunar iDXA; GE Healthcare) followed by a graded exercise test conducted on an electronically braked cycle ergometer (Lode, Groningen, The Netherlands). Maximum effort was confirmed using criteria from the American College of Sports Medicine (30). Multisensor activity monitors (SenseWear MF Armband, BodyMedia) were used to determine free-living physical activity.
Skeletal muscle biopsy and insulin sensitivity
Approximately 4 days following the exercise test, subjects reported to the Clinical and Translational Research Center at ~5.00 pm, were fed a standard meal (10 kcal/kg; 50% carbohydrate, 15% protein, 35% fat), and then fasted until the completion of study procedures. Prior to the clamp study and in the fasted state, a muscle biopsy of the vastus lateralis was performed under local anesthesia (10, 31). The biopsy sample was cleaned of adipose tissues, dried, and flash frozen in liquid nitrogen. Hepatic and peripheral insulin sensitivity were determined using a 2-step (2-hour infusion of insulin (Humulin-R) at 15 mU/m2/min, followed by 2 hours at 40 mU/m2/min) hyperinsulinemic euglycemic clamp method in the fasted state (10). Briefly, euglycemia (target 90 mg/dL) was maintained with a variable 20% dextrose infusion enriched with [6,6-2H2]glucose. Rates of glucose disposal and endogenous glucose production were calculated using nonsteady-state equations from plasma [6,6-2H2]glucose enrichment determined by gas chromatography mass spectrometry (10). Indirect calorimetry was used prior to the clamp procedures (baseline) and at the end of each step of the clamp (steady state).
Tissue analyses
In addition to measures of oxidative capacity and mitochondrial respiration (10), portions of the biopsy samples were used for gene expression and protein content.
Gene expression:
Approximately 15 to 20 mg of muscle tissue was used for the determination of gene expression using quantitative real time polymerase chain reaction. RNA was extracted using the RNeasy mini kit (Qiagen 74104, Qiagen, Valencia, CA). cDNA was prepared from 1 µg of RNA using the RT2 First Strand kit (Qiagen 330421; Qiagen, Valencia, CA). The real-time RT2-PCR gene array for human mitochondria biogenesis and function (Qiagen 330321, Qiagen, Valencia, CA) was used to quantify gene expression. Data were normalized to the arithmetic mean of the housekeeping genes B2M, GAPDH, HPRT1, and RPLP0.
Protein expression.
Total protein was extracted from ~30 mg of skeletal muscle tissue using cell lysis buffer (Cell Signaling, Boston, MA) with protease inhibitors (#11836153001, Sigma-Aldrich), as previously described (32). Protein expression was semiquantified by western blot using the following antibodies: FIS1 (#sc-98900, Santa Cruz), MFN2 (#M6444, Sigma-Aldrich), DLP1 (#611112, BD Biosciences), LC3AB (#84557, Cell Signaling), Beclin1 (#3495, Cell Signaling), OPA1 (#612606, BD Biosciences), and BNIP3 (#B7431, Sigma-Aldrich). Proteins were normalized to β-actin (#sc-47778, Santa Cruz), and an internal loading control was used to adjust for gel-to-gel variability. Blots were visualized using Immun-Star WesternC chemiluminescence (BioRad) and imaged with ChemiDoc XRS + (BioRad). Densitometry was completed using ImageJ software.
Statistical analyses
Data are presented as mean ± standard error of the mean. Gene expression data were not considered independent, and were therefore analyzed with partial least-squares correlation (PLSC) (33). The correlation between data projected on the principal singular vectors provides a multivariate generalization of the Pearson product–moment correlation, which can be assessed with a permutation test. For our data, PLSC was performed between a vector for race, mitochondrial function, or physiological variable, x, and the matrix of gene/protein expression data, Y. Initially, PLSC was performed for all gene expression data. Those variables with a partial correlation of 0.2 (absolute value) were retained and PLSC was recalculated and tested with 1000 random permutations of the data. The criterion of a partial correlation of 0.2 was chosen because (1) it tended to yield results that were consistent with finding significant Pearson product–moment correlations, variable by variable, and (2) it was rather conservative (did not inflate the importance of gene expression variables). Missing data were estimated via prediction from linear regression prior to performing the singular value decomposition of the matrix cross-product. The resulting correlation is the same as a standardized (multivariate) mean difference between the groups, the same way a Pearson product–moment correlation is analogous to a 2-sample t-test or analysis of variance, when 1 variable is binary. Results concerning race are presented as means ± standard error of the mean, with latent variables from PLSC noted. For the continuous mitochondrial function or physiological variables, the partial correlations for latent variables along with PLSCs are presented. All analyses were performed with the statistical software, R (34). Correlational analyses of protein expression and mitochondrial function as well as other physiological variables were performed using Pearson product–moment analyses. Statistical significance was assumed at P ≤ .05.
Results
Insulin sensitivity, resting metabolic rate, and maximal aerobic fitness are lower in AAW
Subjects for this study represent a subset of the total participant pool as previously reported (10) owing to limits of tissue availability for gene/protein expression. As demonstrated in the parent study (10), AAW and CW were similar in age, BMI, and weight by design. Peripheral insulin sensitivity, normalized to circulating insulin, was lower in AAW compared to CW, in agreement with our previous report (10). Levels of moderate and vigorous physical activity were similar between the groups. Maximal aerobic fitness and resting metabolic rate, normalized to FFM, were lower in AAW (Table 1) (10).
Table 1.
Subject characteristics.
| AAW (n = 10) | CW (n = 11) | P | |
|---|---|---|---|
| Age | 21.65 ± 0.90 | 23.45 ± 1.76 | .43 |
| Body composition | |||
| BMI, kg/m2 | 24.30 ± 1.02 | 23.45 ± 1.01 | .57 |
| Wt, kg | 66.67 ± 3.49 | 65.36 ± 3.00 | .78 |
| FFM, kg | 47.40 ± 2.33 | 43.01 ± 1.42 | .12 |
| FM, kg | 19.27 ± 1.84 | 22.34 ± 2.00 | .27 |
| Peripheral insulin sensitivity (M/I), mg/min/kgFFM/µU insulin • mL | 0.26 ± 0.05 | 0.36 ± 0.06 | .01 |
| RMR, kcal/d adjusted for FFM | 1247 ± 37 | 1374 ± 35 | .02 |
| Physical activity and fitness | |||
| Moderate activity, min/day | 96.56 ± 11.08 | 70.67 ± 12.56 | .14 |
| Vigorous activity, min/day | 18.13 ± 4.69 | 35.04 ± 16.62 | .36 |
| VO2max, mL/kgFFM/min | 46.48 ± 1.49 | 53.64 ± 2.07 | .01 |
All data are mean ± standard error of the mean.
Abbreviations: BMI, body mass index; Wt, body weight; FFM, fat free mass; FM, fat mass; RMR, resting metabolic rate
Selective genes in pathways associated with inner mitochondrial membrane transport, mitochondrial transport, and outer membrane transport are lower in skeletal muscle from AAW
Our previous data suggest that impaired mitochondrial function is a key variable in predicting the lower insulin sensitivity (10), as well as decreased resting metabolic rate and maximal aerobic fitness (13). Of the 79 genes assessed from a commercially available gene array platform, only 6 were associated with differentiation by race (Fig. 1A–J). These genes included TAZ (partial r = –0.425), TIMM17B (partial r = –0.468), TIMM44 (partial r = –0.315), TIMM8A (partial r = –0.433), TOMM34 (partial r = –0.409), and TSPO (partial r = –0.382). The PLSC r comprising these variables was significant (PLSC r = 0.631; P = .012). Four of the genes downregulated in AAW are associated with inner membrane translocation (TAZ, TIMM44, TIMM17B, and TIMM8A; Fig. 1A). The other 2 genes, TSPO and TOMM34, are associated with mitochondrial transport (Fig. 1B) and outer membrane translocation (Fig. 1E), respectively. There were no racial differences in gene content within the pathways associated with small molecule transport, membrane localization, mitochondrial fission and fusion, targeting proteins to the mitochondria, apoptosis, membrane polarization and potential, or mitochondrial protein import. Thus, selective genes associated with inner mitochondrial membrane transport, mitochondrial transport, and outer membrane transport are decreased in skeletal muscle from AAW.
Figure 1.
Skeletal muscle gene expression analysis. Gene expression was determined from skeletal muscle biopsy samples as described in Materials and Methods from lean (BMI < 25 kg/m2) Caucasian women (CW, n = 10, white bars) and BMI-matched African American women (AAW, n = 11, black bars). Gene associated with (A) Inner membrane translocation, (B) Mitochondrial transport, (C) small molecule transport, (D) membrane localization, (E) outer membrane translocation, (F) mitochondrial fission and fusion, (G) targeting proteins to mitochondria, (H) apoptosis, (I) membrane polarization and potential, and (J) mitochondrial protein import. Data are mean ± standard error of the mean and normalized to CW. BMI, body mass index. *Latent variables retained by PLSC (partial r between—0.32 and -0.47); PLSC r = 0.631; P = .012.
Proteins associated with mitochondrial fission–fusion and autophagy are altered in skeletal muscle from AAW
The mitochondrial network is dynamic, reacts to various stimuli, and is regulated by the fission–fusion and autophagy pathways. Of the fission–fusion proteins, FIS1 (Fig. 2A) and MFN2 (Fig. 2B) were lower, while OPA1 (Fig. 2C) was significantly higher (all P ≤ .05) in skeletal muscle from AAW than from CW. DLP1 (Fig. 2D) was similar between the groups. Regarding the autophagy pathway, LC3A/B (Fig. 2E) was lower, while Beclin1 (Fig. 2F) was higher in AAW than in CW (both P ≤ .05). Thus, proteins in the mitochondrial regulatory pathways of fission–fusion and autophagy are altered in skeletal muscle from AAW.
Figure 2.
Skeletal muscle protein expression. Proteins were extracted from skeletal muscle biopsy samples and quantified as described in Materials and Methods from lean (BMI < 25 kg/m2) Caucasian women (CW, n = 10, white bars) and BMI-matched African American women (AAW, n = 11, black bars). (A) Fission 1 (FIS1), (B) Mitofusin 2 (MFN2), (C) Optic atrophy 1 (OPA1), (D) Dynamin 1 like (DLP1), (E) Light chain 3 A/B (LC3A/B), and (F) Beclin-1. Data are normalized to protein content of β-actin and relative to CW, arbitrarily set to 1. Representative immunoblots (right) for CW and AAW. *P ≤ 0.05, group difference.
Insulin sensitivity is associated with small molecule transport, fission–fusion, and autophagy pathways
Peripheral insulin sensitivity is lower in AAW than in CW and the racial difference is associated with decreased mitochondrial capacity (10). When all subjects were pooled for correlational analyses, genes associated with mitochondrial fusion (MFN1 and MFN2) tended to be positively associated with peripheral insulin sensitivity. In support of the gene expression data, MFN2 protein expression was positively correlated with peripheral insulin sensitivity. With respect to proteins involved in autophagy, Beclin1 was negatively associated with insulin sensitivity, while LC3A/B was positively associated with insulin sensitivity. Several genes associated with the small molecule transport pathway were positively associated with insulin sensitivity (SLC24A4, SLC24A15, SLC24A16, SLC24A27, and SLC24A30). Thus, insulin sensitivity is associated with small molecule transport, fission–fusion, and autophagy pathways (Table 2).
Table 2.
Correlations and partial correlations between insulin sensitivity and mitochondrial gene expression and protein content.
| Parameter | r | P (2-tailed) |
|---|---|---|
| Gene expression | 0.64 | .047 |
| FXC1 | 0.31 | |
| HSPD1 | 0.31 | |
| MFN1 | 0.29 | |
| MPV17 | 0.30 | |
| SLC25A2 | 0.42 | |
| SLC25A13 | 0.31 | |
| SLC25A19 | -0.37 | |
| SLC25A2 | 0.42 | |
| SLC25A23 | -0.32 | |
| UCP2 | 0.36 | |
| Protein content | ||
| MFN2 | 0.51 | .05 |
| Beclin1 | -0.59 | .02 |
| LC3A/B | 0.46 | .09 |
Correlations for gene expression are partial least-squares correlations, with partial correlations for latent variables indicated. Correlations for protein content are independent Pearson product–moment correlations.
Resting metabolic rate is associated with mitochondrial small molecule transport, inner and outer membrane transport, and mitochondrial transport
Resting metabolic rate (RMR) is lower in AAW compared to CW across the lifespan (10, 35) and the difference may be mediated through impaired mitochondrial capacity (13). Genes expressed from 2 pathways positively associated with RMR were small molecule transport (SLC25A4, SLC25A27, and SLC25A30) and inner membrane transport (TIMM17A, TIMM17B, TIMM23, and TIMM50). Thus, genes within the small molecule transport, inner and outer membrane transport, and mitochondrial transport pathways are associated with RMR (Table 3).
Table 3.
Correlations and partial correlations between resting metabolic rate and mitochondrial gene expression and protein content.
| Parameter | r | P (2-tailed) |
|---|---|---|
| Gene expression | 0.81 | .001 |
| MIPEP | 0.41 | |
| MTX2 | 0.33 | |
| SLC25A4 | 0.36 | |
| SLC25A27 | 0.52 | |
| TIMM50 | 0.42 | |
| TOMM34 | 0.34 | |
| Protein content | ||
| DLP1 | –0.49 | .08 |
Correlations for gene expression are partial least-squares correlations, with partial correlations for latent variables indicated. Correlations for Protein content are independent Pearson product-moment correlations.
Maximal aerobic fitness is associated with multiple mitochondrial pathways
VO2max is lower in AAW than in CW (10) and is correlated with mitochondrial content (36) and function (37). In contrast to the associations with RMR, the only gene in the small molecule transport pathway associated with VO2max was SLC25A4. Several genes associated with inner membrane translocation (TAZ, TIMM8A, TIMM17B, and TIMM50) were positively correlated with VO2max. Other genes involved in apoptosis (BCL2 and SOD2) and fission and fusion (MFN1) were correlated with VO2max. Thus, VO2max is associated with multiple mitochondrial pathways (Table 4).
Table 4.
Correlations and partial correlations between maximal aerobic fitness and mitochondrial gene expression.
| Parameter | r | P (2-tailed) |
|---|---|---|
| Gene expression | 0.75 | .003 |
| MFN1 | 0.34 | |
| SOD2 | 0.37 | |
| TAZ | 0.34 | |
| TIMM8A | 0.39 | |
| TIMM17B | 0.40 | |
| TIMM50 | 0.44 | |
| UXT | 0.35 |
Correlations for gene expression are partial least-squares correlations, with partial correlations for latent variables indicated.
Mitochondrial respiration is associated with mitochondrial small molecule and inner membrane transport
Our previous data suggest that mitochondrial respiration is lower in AAW under basal, maximal coupled, and maximal uncoupled respiration independent of mitochondrial content and muscle fiber type (10). Under conditions of carbohydrate-supported respiration, basal (5 genes) and maximal coupled respiration (6 genes) were associated with genes within the inner mitochondrial membrane transport, mitochondrial transport, small molecule transport, and apoptotic pathways. In contrast, under conditions of carbohydrate with palmitate, basal (8 genes), maximal coupled (8 genes), and maximal uncoupled respiration (8 genes) were associated with genes within the inner membrane transport, mitochondrial transport, small molecule transport, and apoptotic pathways. These data further support the observations of associations linking mitochondrial gene expression with insulin sensitivity, RMR, and VO2max (Table 5).
Table 5.
Correlations and partial correlations between mitochondrial respiration and mitochondrial gene expression.
| Parameter | r | P (2-tailed) | Parameter | r | P (2-tailed) |
|---|---|---|---|---|---|
| Carbohydrate supported | Carbohydrate/palmitate supported | ||||
| Basal | 0.683 | .009 | Basal | 0.682 | .016 |
| SLC25A4 | –0.46 | SLC25A1 | –0.34 | ||
| SOD2 | 0.42 | SLC25A2 | –0.29 | ||
| TIMM17B | 0.44 | SLC25A4 | 0.29 | ||
| TIMM50 | 0.53 | SOD2 | 0.28 | ||
| TIMM8A | 0.38 | TAZ | 0.42 | ||
| TIMM17B | 0.36 | ||||
| TIMM23 | 0.30 | ||||
| TIMM50 | 0.49 | ||||
| Maximal coupled | 0.651 | .050 | Maximal coupled | 0.620 | .041 |
| SLC25A14 | –0.35 | SLC25A1s | –0.29 | ||
| SLC25A2 | –0.43 | SLC25A4 | 0.34 | ||
| STARD3 | –0.38 | SOD2 | 0.44 | ||
| TIMM17B | 0.39 | TAZ | 0.32 | ||
| TIMM8A | 0.41 | TIMM17B | 0.37 | ||
| TIMM8B | 0.35 | TIMM44 | 0.28 | ||
| TIMM50 | 0.44 | ||||
| TIMM8A | 0.30 | ||||
| Maximal uncoupled | 0.630 | .086 | Maximal uncoupled | 0.621 | .039 |
| SLC25A10 | –0.32 | ||||
| SLC25A4 | 0.34 | ||||
| SOD2 | 0.38 | ||||
| TAZ | 0.37 | ||||
| TIMM17B | 0.40 | ||||
| TIMM44 | 0.27 | ||||
| TIMM50 | 0.42 | ||||
| TIMM8A | 0.32 |
Correlations for gene expression are partial least-squares correlations, with partial correlations for latent variables indicated.
Discussion
The overall goal of this study was to determine if pathways associated with skeletal muscle mitochondrial dynamics are impaired in lean AAW compared with CW. A second goal was to examine the skeletal muscle gene expression and protein content across all subjects to better understand the relative contribution of these factors to the physiological variables known to be racially different (10, 13). This study revealed several novel findings. First, we present evidence that selective genes within the mitochondrial pathways of (1) inner membrane translocation, (2) mitochondrial transport, (3) outer membrane translocation, and (4) targeting proteins to mitochondria pathways are lower in skeletal muscle from lean AAW. Second, we demonstrate that several key proteins associated with fission–fusion and autophagy are altered in skeletal muscle from AAW. Finally, key phenotypic variables, demonstrated to be different between AAW and CW, were highly correlated with genes associated with several mitochondrial pathways, as well as proteins related to fission–fusion and autophagy. Together these data suggest that although there were no universal differences in the main pathways between lean AAW and CW, alterations in protein content for fission–fusion and autophagy between the racial groups may contribute to, or be reflective of, mitochondrial dysfunction in AAW predisposing them to increased prevalence of obesity and development of type 2 diabetes.
Mitochondrial function is regulated by a variety of factors encoded by mitochondrial and nuclear DNA (38) representing over 1000 different proteins (39). Recent evidence suggests that pathways associated with mitochondrial energy metabolism are altered in adipose tissue from African Americans (40). Further, mtDNA is reduced in prostate cancer cells in African American men (41) and may be linked to other cancer health disparities (42).
In our cohort of lean women of similar age and activity levels, we demonstrate very few significant racial differences in expression of the 79 mitochondrial genes examined in skeletal muscle. Nevertheless, there is evidence to suggest that perhaps alterations of these genes may contribute to decreased insulin sensitivity, resting metabolic rate, and maximal aerobic fitness all of which are lower in AAW (10). In support of this hypothesis, several genes, which may contribute to our observed racial phenotype, are correlated with mitochondrial function. Although this correlation does not imply causation, a better understanding of the contribution of altered mitochondrial gene expression in skeletal muscle to racial differences in phenotype is needed.
The inner mitochondrial membrane contains the key complexes necessary for the generation of ATP. Yet, central to mitochondrial function is the membrane transport capacity and ultrastructure of the mitochondria. The contribution of changes in inner membrane translocation to mitochondrial function is supported by lower gene expression (TAZ, TIMM8A, and TIMM17B) in AAW than in CW. The transacylase Tafazzin (TAZ) modulates cardiolipin, the phospholipid necessary for mitochondrial structure, fission–fusion, and mitophagy (43). In humans (44) and rodents (45), inactivation of TAZ results in impaired mitochondrial structure and function (46). Phosphorylation of TAZ by GSK-3β, a kinase associated with type 2 diabetes and obesity, results in proteasomal degradation (47) and decreased phosphorylation of IRS1 in vitro (48). Conversely, activation of TAZ protects against lipid induced insulin resistance in skeletal muscle (49). The combination of lower TAZ gene expression in AAW combined with the correlation of TAZ and mitochondrial respiration across all subjects is strongly suggestive of a role for TAZ in mediating the racial differences in mitochondrial function (10).
The translocase proteins of the inner mitochondrial membrane are chaperones for proteins into the mitochondria (50). We demonstrate that the gene expression from 2 members of this family (TIMM8A and TIMM17B) are lower in skeletal muscle from AAW than in CW. TIMM17B forms a membrane pore with TIMM23 to facilitate the import of the proteome, thus contributing to mitochondrial biogenesis (51). A mutation in the TIMM8A protein has been associated with Mohr–Tranebjaerg syndrome characterized by progressive dystonia, decreased visual acuity, and dementia (52). Further study of TIMM8A has revealed that TIMM8A plays a role in the activation of dynamin 1-like protein (Dlp1 or Drp1)-mediated fission during apoptosis (53). Thus, decreased levels of TIMM17B may be reflective of attenuated capacity for mitochondrial fission/fusion and ultimately altered bioenergetics. In support of this hypothesis, a recent study demonstrated an upregulation of several translocase proteins in response to chronic exercise training in skeletal muscle from older male and female subjects (54). These data, in addition to our demonstration that several genes are correlated with aerobic fitness and mitochondrial respiration across all subjects, supports the notion that decreased expression of these genes in skeletal muscle may contribute to our demonstrated racial phenotype differences (10).
The mitochondrial translocator protein (TSPO) is involved in cholesterol transport and steroidogenesis (55). Although TSPO is best characterized in neuronal tissue, it is expressed in metabolically active tissues like skeletal muscle (56). TSPO has been demonstrated to play a role in mediating LPS-induced inflammation in microglia (57). A lack of TSPO in fibroblasts (58) and microglial cells (59) developed from TSPO knockout mice demonstrated lower oxygen consumption, mitochondrial membrane potential, and ATP synthesis. Further, TSPO gene expression is lower in peripheral blood mononuclear cells from patients with multiple sclerosis (60), a condition associated with mitochondrial dysfunction (61). Together, these data support the notion that altered TSPO gene expression in skeletal muscle from AAW may contribute to the mitochondrial dysfunction observed in these subjects.
The translocase of the outer mitochondrial membrane 34 (TOMM34) has been characterized as a cochaperone for heat shock proteins (HSPs) (HSP70 and HSP90) (62) and associated with cancer cell growth (63, 64). HSPs have been associated with insulin sensitivity in rodents and humans through the activation of inflammatory signaling pathways (eg, c-Jun) (65). Moreover, African American prostate cancer cells have been demonstrated to express lower levels of HSPs than Caucasian cells and exhibit greater mitochondrial dysfunction (66). Thus, it is tempting to speculate that lower TOMM34 as observed in our cohort of AAW may be associated with lower skeletal muscle HSP and an enhanced inflammatory milieu contributing to reduced insulin sensitivity and mitochondrial dysfunction. TOMM34 is transcriptionally regulated by nuclear respiratory factor 1 (NRF1) (67), a key factor mediating mitochondrial biogenesis (68). Thus, our demonstration of lower mitochondrial content in AAW (10) supports the observation of lower TOMM34 in skeletal muscle from AAW.
The opposing processes of mitochondrial fission and fusion are finely regulated by a number of proteins, including MFN1, MFN2, OPA1, DRP1, and FIS1. Alterations in the proper balance in these 2 processes are associated with mitochondrial dysfunction, oxidative stress and insulin resistance in skeletal muscle (25, 26, 58, 69). We previously demonstrated that when compared with sedentary subjects of varying ages, several proteins in the fission–fusion (FIS1, DLP1, MFN2, and OPA1) and autophagy (Beclin-1) pathways were higher in skeletal muscle from young physically active subjects who had concomitantly higher levels of mitochondrial respiration and maximal aerobic fitness (70). In support of those observations, we demonstrate that lower skeletal muscle protein content of FIS1 and MFN2 in AAW is concomitant with lower insulin sensitivity. In contrast, we demonstrate higher Beclin-1 protein content in skeletal muscle from AAW than from CW. This difference in skeletal muscle Beclin-1 and insulin sensitivity between the studies may be due to Beclin’s complex nature in terms of protein binding activity (71) and other as of yet defined functions. In support of our current observations, skeletal muscle Beclin-1 mRNA expression in ob/ob mice (72) and protein content following immobilization (73) are elevated concomitant with impaired insulin sensitivity. Thus, additional studies are necessary to better understand the association between Beclin-1 regulation, autophagy, and insulin resistance.
In rodents and humans, skeletal muscle MFN2 is associated with mitochondrial metabolism, oxidative stress, insulin resistance, obesity, and early onset type 2 diabetes (74–76). Further, skeletal muscle MFN2 is affected by acute (28) and chronic exercise (26), both demonstrated to increase insulin sensitivity. The combination of lower MFN2 protein content in AAW and positive correlation with insulin sensitivity across all subjects provides supportive evidence to the notion of a direct link between skeletal muscle MFN2 content and insulin sensitivity. Taken together, our data suggest a dysregulation of the proteins involved in fission, fusion, and autophagy in skeletal muscle from AAW. The alterations of these proteins likely contribute to the observed phenotype of decreased insulin sensitivity, resting metabolic rate, and maximal aerobic fitness.
This study is not without limitations. We acknowledge that the samples size is relatively low to establish any firm conclusions regarding the contributions of altered gene expression in skeletal muscle from AAW to the observed phenotype. However, the fact that our subjects were matched for BMI, physical activity, and age (10) significantly limits several confounding factors to this type of analysis. Moreover, racial differences in gene expression remained even after adjusting for levels of vigorous physical activity. It is accepted that there were very few genes demonstrated to be lower in AAW than in CW despite substantial differences in insulin sensitivity (26%) and mitochondrial respiration (25%). To bolster the evidence of altered gene expression in these lean AAW, we have added an analysis of complementary proteins known to contribute to alteration in insulin sensitivity and mitochondrial respiration. Although this is not an all-inclusive analysis, these data provide the foundation for additional studies to better understand the racial disparity in insulin resistance and increased risk for the development of type 2 diabetes in AAW.
In conclusion, the incidence of obesity, reduced insulin sensitivity, and risk for development of type 2 diabetes is higher in AAW than in CW. The etiology of this racial disparity is currently unknown. Our novel data provide evidence for alterations in mitochondrial gene expression and protein content in several pathways associated with mitochondrial function including small molecule, inner, and outer membrane transport as well as fission, fusion, and autophagy in skeletal muscle from lean AAW. Furthermore, these pathways are associated with RMR and maximal aerobic capacity, key factors associated with weight gain and insulin action. Although the exact mechanism contributing to the alterations in these genes and proteins is unknown, this may provide the foundation leading to the increased risk for development of type 2 diabetes in AAW.
Acknowledgments
We would like to thank the participants in the study, as well as the administrative and technical support staff.
Financial Support: This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK091462 (to JPD) and National Institutes of Health Grant UL1TR000005 (Clinical and Translational Research Center).
Author Contributions: J.J.D. and J.P.D. were the project leaders and contributed to all aspects of this work. All authors performed experiments, contributed intellectually, and reviewed/edited the manuscript. J.P.D. is the guarantor of this work.
Glossary
Abbreviations
- AAW
African American women
- BMI
body mass index
- CW
Caucasian women
- RMR
resting metabolic rate
- PLSC
partial least-squares correlation
- VO2max
maximal aerobic fitness
Additional Information
Disclosure Summary: The authors report no conflicts of interest.
Data availability: The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.
References
- 1. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004;89(6):2590–2594. [DOI] [PubMed] [Google Scholar]
- 2. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29(6):1263–1268. [DOI] [PubMed] [Google Scholar]
- 3. Okosun IS. Racial differences in rates of type 2 diabetes in American women: how much is due to differences in overall adiposity? Ethn Health. 2001;6(1):27–34. [DOI] [PubMed] [Google Scholar]
- 4. Paeratakul S, Lovejoy JC, Ryan DH, Bray GA. The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults. Int J Obes Relat Metab Disord. 2002;26(9):1205–1210. [DOI] [PubMed] [Google Scholar]
- 5. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2017. [Google Scholar]
- 6. Miyazaki Y, DeFronzo RA. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol. 2009;(8):44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kim C, Harlow SD, Karvonen-Gutierrez CA, et al. Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women’s Health Across the Nation. Diabet Med. 2013;30(12):1433–1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Lovejoy JC, Smith SR, Rood JC. Comparison of regional fat distribution and health risk factors in middle-aged white and African American women: The Healthy Transitions Study. Obes Res. 2001;9(1):10–16. [DOI] [PubMed] [Google Scholar]
- 9. North KE, Graff M, Franceschini N, et al. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study. Eur J Gastroenterol Hepatol. 2012;24(1):9–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. DeLany JP, Dubé JJ, Standley RA, et al. Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity. J Clin Endocrinol Metab. 2014;99(11):4307–4314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Jakicic JM, Wing RR. Differences in resting energy expenditure in African-American vs Caucasian overweight females. Int J Obes Relat Metab Disord. 1998;22(3):236–242. [DOI] [PubMed] [Google Scholar]
- 12. Weinsier RL, Hunter GR, Zuckerman PA, et al. Energy expenditure and free-living physical activity in black and white women: comparison before and after weight loss. Am J Clin Nutr. 2000;71(5):1138–1146. [DOI] [PubMed] [Google Scholar]
- 13. Toledo FGS, Dubé JJ, Goodpaster BH, Stefanovic-Racic M, Coen PM, DeLany JP. Mitochondrial respiration is associated with lower energy expenditure and lower aerobic capacity in African American women. Obesity (Silver Spring). 2018;26(5):903–909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Goodpaster BH. Mitochondrial deficiency is associated with insulin resistance. Diabetes. 2013;62(4):1032–1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Holloszy JO. “Deficiency” of mitochondria in muscle does not cause insulin resistance. Diabetes. 2013;62(4):1036–1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Toledo FG. Mitochondrial involvement in skeletal muscle insulin resistance. Diabetes. 2014;63(1):59–61. [DOI] [PubMed] [Google Scholar]
- 17. Chomentowski P, Coen PM, Radiková Z, Goodpaster BH, Toledo FG. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab. 2011;96(2):494–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. van de Weijer T, Sparks LM, Phielix E, et al. Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus. PLoS One. 2013;8(2):e51648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Anderson EJ, Lustig ME, Boyle KE, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009;119(3):573–581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bleau C, Karelis AD, St-Pierre DH, Lamontagne L. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes. Diabetes Metab Res Rev. 2015;31(6):545–561. [DOI] [PubMed] [Google Scholar]
- 21. Turner N, Bruce CR, Beale SM, et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes. 2007;56(8):2085–2092. [DOI] [PubMed] [Google Scholar]
- 22. Seyssel K, Alligier M, Meugnier E, et al. Regulation of energy metabolism and mitochondrial function in skeletal muscle during lipid overfeeding in healthy men. J Clin Endocrinol Metab. 2014;99(7):E1254–E1262. [DOI] [PubMed] [Google Scholar]
- 23. Bach D, Naon D, Pich S, et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes. 2005;54(9):2685–2693. [DOI] [PubMed] [Google Scholar]
- 24. Zorzano A, Liesa M, Palacín M. Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch Physiol Biochem. 2009;115(1):1–12. [DOI] [PubMed] [Google Scholar]
- 25. Bach D, Pich S, Soriano FX, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003;278(19):17190–17197. [DOI] [PubMed] [Google Scholar]
- 26. Sebastián D, Hernández-Alvarez MI, Segalés J, et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A. 2012;109(14):5523–5528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Fealy CE, Mulya A, Lai N, Kirwan JP. Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle. J Appl Physiol (1985). 2014;117(3):239–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Cartoni R, Léger B, Hock MB, et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005;567(Pt 1):349–358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Greene NP, Lee DE, Brown JL, et al. Mitochondrial quality control, promoted by PGC-1alpha, is dysregulated by Western diet-induced obesity and partially restored by moderate physical activity in mice. Physiol Rep. 2015;3(7):e12470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Riebe D, Ehrman JK, Liguori G, Magal M. ACSM’s Guidelines for Exercise testing and Prescription. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2018. [Google Scholar]
- 31. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest. 1975;35(7):609–616. [PubMed] [Google Scholar]
- 32. Dubé JJ, Amati F, Toledo FG, et al. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia. 2011;54(5):1147–1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Abdi H, Williams LJ. Partial least squares methods: partial least squares correlation and partial least square regression. Methods Mol Biol. 2013;930:549–579. [DOI] [PubMed] [Google Scholar]
- 34. RC T. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. [Google Scholar]
- 35. Santa-Clara H, Szymanski L, Ordille T, Fernhall B. Effects of exercise training on resting metabolic rate in postmenopausal African American and Caucasian women. Metabolism. 2006;55(10):1358–1364. [DOI] [PubMed] [Google Scholar]
- 36. Hoppeler H, Lüthi P, Claassen H, Weibel ER, Howald H. The ultrastructure of the normal human skeletal muscle. A morphometric analysis on untrained men, women and well-trained orienteers. Pflugers Arch. 1973;344(3):217–232. [DOI] [PubMed] [Google Scholar]
- 37. Jacobs RA, Lundby C. Mitochondria express enhanced quality as well as quantity in association with aerobic fitness across recreationally active individuals up to elite athletes. J Appl Physiol (1985). 2013;114(3):344–350. [DOI] [PubMed] [Google Scholar]
- 38. Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Fox TD. Mitochondrial protein synthesis, import, and assembly. Genetics. 2012;192(4):1203–1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Das SK, Sharma NK, Zhang B. Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African Americans. BMC Med Genomics. 2015;8:4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Koochekpour S, Marlowe T, Singh KK, Attwood K, Chandra D. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men. PLoS One. 2013;8(9):e74688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Choudhury AR, Singh KK. Mitochondrial determinants of cancer health disparities. Semin Cancer Biol. 2017;47:125–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Hsu P, Liu X, Zhang J, Wang HG, Ye JM, Shi Y. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy. Autophagy. 2015;11(4):643–652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Spencer CT, Byrne BJ, Gewitz MH, et al. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol. 2005;26(5):632–637. [DOI] [PubMed] [Google Scholar]
- 45. Acehan D, Vaz F, Houtkooper RH, et al. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem. 2011;286(2):899–908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Xu Y, Sutachan JJ, Plesken H, Kelley RI, Schlame M. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab Invest. 2005;85(6):823–830. [DOI] [PubMed] [Google Scholar]
- 47. Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94(4):1287–1312. [DOI] [PubMed] [Google Scholar]
- 48. Wang C, Jeong K, Jiang H, et al. YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer. Am J Cancer Res. 2016;6(5):996–1010. [PMC free article] [PubMed] [Google Scholar]
- 49. Jung JG, Yi SA, Choi SE, et al. TM-25659-Induced Activation of FGF21 Level Decreases Insulin Resistance and Inflammation in Skeletal Muscle via GCN2 Pathways. Mol Cells. 2015;38(12):1037–1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci U S A. 1999;96(5):2141–2146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Sinha D, Srivastava S, Krishna L, D’Silva P. Unraveling the intricate organization of mammalian mitochondrial presequence translocases: existence of multiple translocases for maintenance of mitochondrial function. Mol Cell Biol. 2014;34(10):1757–1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Tranebjaerg L. Deafness-dystonia-optic neuronopathy syndrome. In: Pagon RA, Adam MP, Ardinger HH, et al. , eds. GeneReviews(R). Seattle, WA: University of Washington; 1993. [PubMed] [Google Scholar]
- 53. Arnoult D, Rismanchi N, Grodet A, et al. Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr Biol. 2005;15(23):2112–2118. [DOI] [PubMed] [Google Scholar]
- 54. Alway SE, McCrory JL, Kearcher K, et al. Resveratrol enhances exercise-induced cellular and functional adaptations of skeletal muscle in older men and women. J Gerontol A Biol Sci Med Sci. 2017;72(12):1595–1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Gatliff J, Campanella M. TSPO is a REDOX regulator of cell mitophagy. Biochem Soc Trans. 2015;43(4):543–552. [DOI] [PubMed] [Google Scholar]
- 56. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327(1-2):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Bae KR, Shim HJ, Balu D, Kim SR, Yu SW. Translocator protein 18 kDa negatively regulates inflammation in microglia. J Neuroimmune Pharmacol. 2014;9(3):424–437. [DOI] [PubMed] [Google Scholar]
- 58. Zhao AH, Tu LN, Mukai C, et al. Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis. J Biol Chem. 2016;291(4):1591–1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Banati RB, Middleton RJ, Chan R, et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat Commun. 2014;5:5452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Harberts E, Datta D, Chen S, Wohler JE, Oh U, Jacobson S. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients. J Neuroimmune Pharmacol. 2013;8(1):51–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Barcelos IP, Troxell RM, Graves JS. Mitochondrial dysfunction and multiple sclerosis. Biology (Basel). 2019;8(2):37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Trcka F, Durech M, Man P, Hernychova L, Muller P, Vojtesek B. The assembly and intermolecular properties of the Hsp70-Tomm34-Hsp90 molecular chaperone complex. J Biol Chem. 2014;289(14):9887–9901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Aleskandarany MA, Negm OH, Rakha EA, et al. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Res Treat. 2012;136(2):419–427. [DOI] [PubMed] [Google Scholar]
- 64. Shimokawa T, Matsushima S, Tsunoda T, Tahara H, Nakamura Y, Furukawa Y. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol. 2006;29(2):381–386. [PubMed] [Google Scholar]
- 65. Chung J, Nguyen AK, Henstridge DC, et al. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A. 2008;105(5):1739–1744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Chaudhary AK, O’Malley J, Kumar S, et al. Mitochondrial dysfunction and prostate cancer racial disparities among American men. Front Biosci (Schol Ed). 2017;9:154–164. [DOI] [PubMed] [Google Scholar]
- 67. Blesa JR, Prieto-Ruiz JA, Abraham BA, Harrison BL, Hegde AA, Hernández-Yago J. NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene. Biochem Cell Biol. 2008;86(1):46–56. [DOI] [PubMed] [Google Scholar]
- 68. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, Tarnopolsky MA. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem. 2011;286(12):10605–10617. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 69. Jheng HF, Tsai PJ, Guo SM, et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol. 2012;32(2):309–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Distefano G, Standley RA, Dubé JJ, et al. Chronological age does not influence ex-vivo mitochondrial respiration and quality control in skeletal muscle. J Gerontol A Biol Sci Med Sci. 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18(4):571–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Turpin SM, Ryall JG, Southgate R, et al. Examination of ‘lipotoxicity’ in skeletal muscle of high-fat fed and ob/ob mice. J Physiol. 2009;587(Pt 7):1593–1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Kang C, Yeo D, Ji LL. Muscle immobilization activates mitophagy and disrupts mitochondrial dynamics in mice. Acta Physiol (Oxf). 2016;218(3):188–197. [DOI] [PubMed] [Google Scholar]
- 74. Molina AJ, Bharadwaj MS, Van Horn C, et al. Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance. JACC Heart Fail. 2016;4(8):636–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Pattanakuhar S, Sutham W, Sripetchwandee J, et al. Combined exercise and calorie restriction therapies restore contractile and mitochondrial functions in skeletal muscle of obese-insulin resistant rats. Nutrition. 2019;62:74–84. [DOI] [PubMed] [Google Scholar]
- 76. Civitarese AE, MacLean PS, Carling S, et al. Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. Cell Metab. 2010;11(5):412–426. [DOI] [PMC free article] [PubMed] [Google Scholar]


